126 related articles for article (PubMed ID: 25123133)
1. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
[TBL] [Abstract][Full Text] [Related]
2. RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.
Riuzzi F; Sorci G; Sagheddu R; Sidoni A; Alaggio R; Ninfo V; Donato R
J Cell Sci; 2014 Apr; 127(Pt 8):1699-711. PubMed ID: 24554430
[TBL] [Abstract][Full Text] [Related]
3. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
[TBL] [Abstract][Full Text] [Related]
4. HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK- and myogenin-dependent repression of Pax7 transcription.
Riuzzi F; Sorci G; Sagheddu R; Donato R
J Cell Sci; 2012 Mar; 125(Pt 6):1440-54. PubMed ID: 22328527
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
[TBL] [Abstract][Full Text] [Related]
6. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
Riuzzi F; Sorci G; Donato R
Am J Pathol; 2007 Sep; 171(3):947-61. PubMed ID: 17640970
[TBL] [Abstract][Full Text] [Related]
7. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
[TBL] [Abstract][Full Text] [Related]
8. Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?
Blake J; Ziman MR
Histol Histopathol; 2003 Apr; 18(2):529-39. PubMed ID: 12647804
[TBL] [Abstract][Full Text] [Related]
9. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
10. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
11. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
12. Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.
Nanni P; Nicoletti G; Palladini A; Astolfi A; Rinella P; Croci S; Landuzzi L; Monduzzi G; Stivani V; Antognoli A; Murgo A; Ianzano M; De Giovanni C; Lollini PL
Mol Cancer Ther; 2009 Apr; 8(4):754-61. PubMed ID: 19372547
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma.
Ignatius MS; Chen E; Elpek NM; Fuller AZ; Tenente IM; Clagg R; Liu S; Blackburn JS; Linardic CM; Rosenberg AE; Nielsen PG; Mempel TR; Langenau DM
Cancer Cell; 2012 May; 21(5):680-693. PubMed ID: 22624717
[TBL] [Abstract][Full Text] [Related]
14. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
[TBL] [Abstract][Full Text] [Related]
15. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
16. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors.
de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR
Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386
[TBL] [Abstract][Full Text] [Related]
17. CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.
Liu Z; Zhang X; Lei H; Lam N; Carter S; Yockey O; Xu M; Mendoza A; Hernandez ER; Wei JS; Khan J; Yohe ME; Shern JF; Thiele CJ
Nat Commun; 2020 Feb; 11(1):911. PubMed ID: 32060262
[TBL] [Abstract][Full Text] [Related]
18. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells.
Tiffin N; Williams RD; Shipley J; Pritchard-Jones K
Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
Belyea BC; Naini S; Bentley RC; Linardic CM
Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
[TBL] [Abstract][Full Text] [Related]
20. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]